Grifols is committed to quality
Grifols owns one of the largest plasma collection networks in the world, and is committed to ensuring that its products meet excellent quality standards and are available to the patients who need them.
One of the largest plasma collection networks in the world, with a production capacity you can rely on1
All donors thoroughly screened and tested
Identification and verification by barcodes
Full traceability from each donation to final product
Immunoassay (ELISA) testing for each donation
Each unit is tested by ELISA for HBsAg, HIVAb, and HCVAb
Minipool nucleic acid testing (NAT)
NAT testing in minipools of ≤512 units for HIV, HBV, HCV, HAV, and virus B19
Every unit of plasma is held in inventory for 60 days before being released into production
Final computer verification
The only way plasma is released
ELISA, enzyme-linked immunosorbent assay; HAV, hepatitis A virus; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; HCVAb, hepatitis C virus antibody; HIV, human immunodeficiency virus; HIVAb, human immunodeficiency virus antibody.